On Tuesday, Tyco International PLC (NYSE:TYC)’s shares declined -1.79% to $37.84.
Tyco (TYC) stated $0.44 in GAAP diluted earnings per share (EPS) from ongoing operations for the fiscal third quarter of 2015 and diluted EPS from ongoing operations before special items of $0.59. Revenue of $2.5 billion in the quarter reduced 6% as compared to the preceding year, primarily due to a 7% negative impact of the stronger U.S. dollar against foreign currencies. Organic revenue declined 1% in the quarter. Acquisitions contributed 2 percentage points of growth, which was partially offset by the impact of a divestiture.
Tyco International Ltd. designs, sells, installs, and services security, fire detection, suppression, and life safety products worldwide. It operates in three segments: North America Installation & Services, Rest of World Installation & Services, and Global Products. Its electronic security systems comprise detection devices; asset protection and security administration systems; anti-theft systems; access control solutions, such as integrated security administration systems, access control solutions applications, alarm administration panels, door controllers, readers, keypads, and cards; video system solutions, such as digital video administration systems, matrix switchers and controllers, digital multiplexers, programmable cameras, monitors, and liquid crystal interactive displays; and burglar alarms and interactive security systems, such as alarm control panels, keypads, sensors, and central station receiving equipment for homes and businesses.
Medivation Inc (NASDAQ:MDVN)’s shares showed no change to $100.74.
Medivation, Inc. ( MDVN) stated its financial results for the second quarter ended June 30, 2015. U.S. net sales of XTANDI® (enzalutamide) capsules, as stated by Astellas Pharma Inc., were $298.4 million for the quarter (+108% vs. preceding year). Second quarter U.S. net sales raised by 33% contrast with first quarter 2015 net sales of $224.0 million. We estimate second quarter 2015 unit demand raised by a low- to mid-teens percentage rate, contrast with unit demand in the first quarter 2015. In addition, based on information offered by Astellas, a lower gross-to-net discount rate was applied to second quarter gross sales (contrast with the first quarter rate), and a $2.8 million favorable adjustment was recorded in the second quarter by Astellas with respect to gross-to-net discount related to previous period gross sales.
Medivation, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat serious diseases in the United States. It offers XTANDI for the treatment of post-chemotherapy metastatic castration-resistant prostate cancer (mCRPC) patients.
At the end of Tuesday’s trade, Aon Plc (NYSE:AON)‘s shares dipped -1.41% to $101.32.
Impact Forecasting, Aon Benfield’s catastrophe model development team, recently launches the latest edition of its monthly Global Catastrophe Recap report, which evaluates the impact of the natural disaster events that occurred worldwide during July 2015. Aon Benfield is the global reinsurance intermediary and capital advisor of Aon plc (AON).
The report reveals that Typhoon Chan-hom tracked across much of the Western Pacific Ocean during the month, causing extensive damage in China, Japan’s Okinawa Island chain, South Korea, Taiwan and Guam, killing at least six people and injuring 30 others.
Total economic losses were estimated at more than USD1.6 billion, with China bearing the greatest impact; according to China’s Ministry of Civil Affairs, damage from Chan-hom had resulted in a CNY9.1 billion (USD1.5 billion) economic loss, mainly as a result of damage to agricultural interests and infrastructure.
Aon plc provides risk administration services, insurance and reinsurance brokerage, and human resource consulting and outsourcing services worldwide. It operates through two segments, Risk Solutions and HR Solutions. The Risk Solutions segment offers retail brokerage services, counting affinity products, managing general underwriting, placement, captive administration services, and data and analytics; risk administration solutions for property liability, general liability, professional liability, directors’ and officers’ liability, workers’ compensation, and various healthcare products; and health and benefits consulting services comprising structuring, funding, and administering employee benefit programs. This segment also provides advisory services to technology, financial services, agribusiness, aviation, construction, health care, energy, and other industries.
C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW), ended its Tuesday’s trading session with 0.37% gain, and closed at $69.84.
C.H. Robinson Worldwide, Inc. (CHRW) declared that its Board of Directors recently declared a regular quarterly cash dividend of 38 cents ($0.38) per share, payable on September 30, 2015, to shareholders of record on September 4, 2015.
C.H. Robinson has distributed regular dividends for more than twenty-five years. As of August 6, 2015, there were about 141,801,035 shares outstanding.
C.H. Robinson Worldwide, Inc., a third party logistics company, provides freight transportation services and logistics solutions to companies in various industries worldwide. It offers transportation and logistics services, such as truckload comprising time-definite and expedited truck transportation services; less than truckload services; intermodal transportation, which is shipment service of freight in trailers or containers by combination of truck and rail; and non-vessel ocean common carrier or freight forwarding services, in addition to organizes air shipments and provides door-to-door services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.